Sunday, June 9, 2013 | ||
08.30 - 10.00 | Concurrent Symposia S01 - S04 | |
S01. Chromatin organisation and gene expressionS01.1 Evolutionary pressures and gene expression regulation, Yoav Gilad, United States S01.2 Chromosomal rearrangements and gene expression, Alexandre Reymond, Switzerland S01.3 Variation in Gene Regulation, Chromatin States and Protein Levels across Human Individuals and Populations, Mike Snyder, United States S02. From genes to treatment in multifactorial diseasesS02.1 The search for bone and joint genes, and what to do with them?, André G. Uitterlinden, The Netherlands S02.2 Inflammatory bowel disease: From genes to clinical impact?, Carl Anderson, United Kingdom S02.3 From genetics to translation in SCD, Rob Graham, United States S03. Gene regulation in cancerS03.1 Lynch syndrome as a model of mutations and epimutations in cancer, Päivi Peltomäki, Finland S03.2 Epigenetic programming of the cancer phenotype, Jean-Pierre Issa , United States S03.3 Insights into oncogenesis from cancer predisposition genes, Nazneen Rahman, United Kingdom S04. Emerging topics in neurobiologyS04.1 The role of microglia in synaptogenesis, Cornelius Gross, Italy S04.2 The role of glia in neurodegenerative diseases, Don Cleveland, United States S04.3 Molecular genetics of axon degeneration, Michael Coleman, United Kingdom | ||
08.30 - 10.00 | Educational Session 3 | |
ES3. Tweeting about GenomicsES3.1 Understanding Genomics. Trends in Science Communication, Anne Dijkstra, The Netherlands ES3.2 Science in the media. Lost in translation, David Secko, Canada | ||
10.00 - 10.30 | Coffee Break, Free Poster Viewing, Exhibition | |
10.30 - 11.30 | Poster Viewing with Authors (Odd poster numbers) | |
11.30 - 13.15 | Free Poster Viewing, Exhibition, Lunch as of 12.15 hrs | |
11.40 - 13.10 | Educational Session 4 | |
ES4. Cancer risk in developmental syndromesES4.1 Cancer risk in overgrowth syndromes, Andrea Riccio, Italy ES4.2 Cancer risk in RASopathies, Karen Gripp, United States | ||
11.40 - 13.10 | Workshops WS01-WS03 | |
WS01. Next Generation sequencing in clinical practice - Filtering and reporting (Joris Veltman & Joris Vermeesch) - View detailsWS02. Debate: Hot topics in preimplantation genetic testing (The-Hung Bui) - View detailsWS03. UCSC Genome Browser I (Robert Kuhn) - View details | ||
11.40 - 13.10 | Corporate Satellites | |
13.15 - 14.45 | Concurrent Sessions C01 - C07 | |
C01. Structural variation and de novo mutationsC02. Genotype phenotype correlationC03. Prenatal diagnosisC04. Cancer predispositionC05. Functional GenomicsC06. Neuromuscular disorders: From genes and modifiers to function and therapyC07. Metabolic and mitochondrial disorders | ||
14.45 - 15.15 | Vitamin Break, Free Poster Viewing, Exhibition | |
| ||
15.15 - 16.45 | Workshops WS04 - WS09 | |
WS04. Dysmorphology 1 (Dian Donnai & Jill Clayton-Smith) - View details | ||
15.15 - 16.45 | Corporate Satellites | |
16.45 - 17.15 | Coffee Break, Free Poster Viewing, Exhibition | |
17.15 - 18.45 | Concurrent Symposia S05 - S08 | |
S05. Interpreting NGS dataS05.1 Analytical challenges of using next-generation sequencing to unlock complex disease, Mark Daly, United States S05.2 Diagnostic exome sequencing in genetic diseases, Lisenka Vissers, The Netherlands S05.3 Prioritizing disease-causing variation by genomic data fusion, Yves Moreau, Belgium S06. Cancer geneticsS06.1 Identification of the gene for mixed polyposis syndrome: the end of a 50-year journey, Ian Tomlinson, United Kingdom S06.2 The role of IL7R in childhood T-cell acute lymphoblastic leukemia, João Taborda Barata, Portugal S06.3 Exosomes in cancer-cell communication, dissemination and therapy-resistence, Lorraine O'Driscoll, Ireland S07. Genetics of skin diseases and new therapiesS07.1 iPS and their therapeutic potentiel for keratinizing disorders, Dennis Roop, United States S07.2 Netherton syndrome and links to eczema, Alain Hovnanian, France S07.3 Artificial Skin, Marcela del Rio, Spain S08. Evolution of organsS08.1 Dissecting the effects of selection in the human genome: the case of immunity to infection, Luis Quintana-Murci, France S08.2 Gene dosage sensitivity and copy-number evolution, Aoife McLysaght, Ireland S08.3 Evolution of vision, Detlef Arendt, Germany | ||
17.15 - 18.45 | Educational Session 5 | |
ES5. EpilepsiesES5.1 Spectrum of monogenic forms and clinical importance of de novo mutations, Stéphanie Baulac, France ES5.2 The role of genetic susceptibility factors in epilepsy and their clinical relevance , Ingo Helbig, Germany | ||
18.45 - 20.15 | Corporate Satellites | |
19.00 - 20.00 | ESHG Membership Meeting |